High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study
April 21, 2022: High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study
Retinoblastoma is the most common eye cancer in childhood. Timely diagnosis and protocol-based management can achieve excellent survival. However, the real-world picture is dismal, with Asia and Africa contributing to the majority of advanced retinoblastoma cases and a high retinoblastoma-associated death rate. This eye cancer foundation-funded registry-based study answers the critical question: what clinical features and tumor size at presentation are associated with high-risk pathology and thus systemic spread? This knowledge will equip the treating physician with the essential information about disease prognosis and allow the parents and physicians to navigate the complex decision-making for the best treatment plan for the child.
Click here to read the full article https://www.aaojournal.org/article/S0161-6420(22)00284-6/fulltext
Retinoblastoma is the most common eye cancer in childhood. Timely diagnosis and protocol-based management can achieve excellent survival. However, the real-world picture is dismal, with Asia and Africa contributing to the majority of advanced retinoblastoma cases and a high retinoblastoma-associated death rate. This eye cancer foundation-funded registry-based study answers the critical question: what clinical features and tumor size at presentation are associated with high-risk pathology and thus systemic spread? This knowledge will equip the treating physician with the essential information about disease prognosis and allow the parents and physicians to navigate the complex decision-making for the best treatment plan for the child.
Click here to read the full article https://www.aaojournal.org/article/S0161-6420(22)00284-6/fulltext
